SIGA - SIGA Technologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
5.99
-0.01 (-0.17%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close6.00
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume35,270
Market Cap473.444M
Beta1.31
PE Ratio (TTM)N/A
EPS (TTM)-0.48
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.00
Trade prices are not sourced from all markets
  • GlobeNewswire15 days ago

    SIGA Technologies Announces FDA Accepts NDA and Grants Priority Review for Oral TPOXX to Treat Smallpox

    NEW YORK, Feb. 07, 2018-- SIGA Technologies, Inc., a health security company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced ...

  • GlobeNewswire2 months ago

    SIGA Technologies Announces FDA Submission of its New Drug Application for oral TPOXX (tecovirimat) to Treat Smallpox

    –Company requests Priority Review of TPOXX NDA–. –If approved, would be the first treatment for deadly smallpox–. NEW YORK, Dec. 11, 2017-- SIGA Technologies, Inc., a health security company specializing ...

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube6 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (ACHN-US, ... Read more (Read more...)

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017
    Capital Cube8 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017

    Categories: Yahoo FinanceGet free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (ACHN-US, ... Read more (Read more...)

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cube11 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc., Newlink Genetics Corporation and NanoViricides, ... Read more (Read more...)